A prime opportunity for pharma to raise its strategic game in ESG.
Jen Nixon
Advertisement
Articles by Jen Nixon
The pharma industry is beginning to perform better with environmental, social, and governance (ESG).
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
